Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31
Phase 42

Trial Status

Recruiting4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06650488Phase 4Recruiting
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Staphylococcus Aureus Bloodstream InfectionStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia
PrincipalinvestigatorStart date: 2026-01-15
NCT06650501Phase 4Recruiting
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
S. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus Bacteremia+3 more
PrincipalinvestigatorStart date: 2026-01-15
NCT04851015Phase 3Recruiting
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
PneumocystisPneumocystis Carinii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+5 more
PrincipalinvestigatorStart date: 2025-11-28
NCT04886284Phase 2Recruiting
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcal SepsisStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis+1 more
PrincipalinvestigatorStart date: 2024-05-20

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Matthew P Cheng, MD

Research Institute of the McGill University Health Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Staphylococcal SepsisStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis+1 more

Worked with same sponsors:

Todd C. Lee MD MPH FIDSA
Collaborated on 1 trial
Similarity Score44%

Todd C Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Related
2 trials

Shared therapeutic areas:

PneumocystisPneumocystis jirovecii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+4 more

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Similarity Score15%

Emily G McDonald, MD MSc

McGill University Health Centre/Research Institute of the McGill University Health Centre

Related
3 trials

Shared therapeutic areas:

PneumocystisPneumocystis jirovecii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+4 more

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Similarity Score15%

Adrien LEMAIGNEN, Dr

University Hospital of TOURS

Related
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis
Similarity Score6%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
Similarity Score4%

Joseph A Kovacs, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
4 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score4%

Alison Morris-Gimbel, MD

University of Pittsburgh

Related
2 trials

Shared therapeutic areas:

PneumocystisPneumonia, Pneumocystis
Similarity Score4%

Robert Murphy

Related
1 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score2%

Todd C. Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Related
2 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Similarity Score2%

Walter T Hughes

Related
1 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06650488Phase 4PrincipalInvestigator

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Staphylococcus Aureus Bloodstream InfectionStaphylococcus Aureus EndocarditisStaphylococcus Aureus Septicemia
Recruiting
NCT06650501Phase 4PrincipalInvestigator

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

S. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus Bacteremia+3 more
Recruiting
NCT04851015Phase 3PrincipalInvestigator

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

PneumocystisPneumocystis Carinii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+5 more
Recruiting
NCT04886284Phase 2PrincipalInvestigator

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Staphylococcal SepsisStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis+1 more
Recruiting

All 4 trials loaded